Inspire Medical Systems (INSP) Capital Expenditures Growth (1y) (2018 - 2026)
Inspire Medical Systems (INSP) Capital Expenditures Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.32 Bn | 177.02 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 68.65 Bn | 67.20 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 47.43 Bn | 43.76 Bn | 1.29 Bn | 15.89% |
| 6 | GE HealthCare Technologies | 28.48 Bn | 26.19 Bn | 1.98 Bn | 106.98% |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | -11.95% |
| 8 | Smith & Nephew | 26.98 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | -47.73% |
| 10 | Inspire Medical Systems | 1.47 Bn | 1.18 Bn | 176.91 Mn | -64.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.48% |
| Dec 31, 2025 | 51.64% |
| Sep 30, 2025 | -21.87% |
| Jun 30, 2025 | -64.65% |
| Mar 31, 2025 | 54.03% |
| Dec 31, 2024 | 160.69% |
| Sep 30, 2024 | 118.52% |
| Jun 30, 2024 | -47.91% |
| Mar 31, 2024 | 45.43% |
| Dec 31, 2023 | -249.12% |
| Sep 30, 2023 | 1,092.17% |
| Jun 30, 2023 | -175.76% |
| Mar 31, 2023 | 208.89% |
| Dec 31, 2022 | 93.57% |
| Sep 30, 2022 | -344.74% |
| Jun 30, 2022 | 218.65% |
| Mar 31, 2022 | -8.02% |
| Dec 31, 2021 | 391.54% |
| Sep 30, 2021 | 183.65% |
| Jun 30, 2021 | -288.05% |